Sanofi Starts Work On Insulin Facility In Germany

By Reuters News

- Sanofi SA SASY.PA:

  • SANOFI BREAKS GROUND ON NEW STATE-OF-THE-ART INSULIN MANUFACTURING FACILITY AT BIOCAMPUS IN FRANKFURT IN GERMANY

  • SANOFI - FULL INSULIN API PRODUCTION PLANNED FOR 2032

  • SANOFI - FRANKFURT BIOCAMPUS HAS 4,000 EMPLOYEES AND SUPPLIES 20 INSULIN PRODUCTS

Source text: ID: nGNX3J12yX

Further company coverage: SASY.PA

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk